Physician profile
Michael E Kirk
NPI 1255349452
$7,583.52
in general payments reported to CMS, 2019-2025
20 companies · $505 in 2025
The $505 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,204 · 2020: $815 · 2021: $2,095 · 2022: $1,945 · 2023: $503 · 2024: $516 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,306 · Consulting Fee: $143 · Travel and Lodging: $74.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,306.06 |
| Consulting Fee | $142.59 |
| Travel and Lodging | $74.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,605.42 | 2019-2024 | Real Intelligence, Journey II, Legion |
| Depuy Synthes Sales INC. | $729.86 | 2019-2025 | Orthovisc, Attune, Dynacord |
| Stryker Corporation | $364.82 | 2019-2025 | Triathlon, Tritanium, Adapt |
| Zimmer Biomet Holdings, INC. | $255.50 | 2023-2025 | Rosa, Oxford |
| Next Science LLC | $142.59 | 2024 | Surgx, Blastx, Xperience |
| Onkos Surgical, INC. | $119.69 | 2025 | Eleos Limb Salvage System |
| Pacira Pharmaceuticals Incorporated | $104.84 | 2021 | |
| Innovation Technologies INC | $39.11 | 2024 | Irrisept |
| Horizon Therapeutics Plc | $36.57 | 2019-2020 | |
| Medartis INC. | $24.35 | 2024 | Aptus |
| Vertex Pharmaceuticals Incorporated | $21.92 | 2025 | |
| Allergan, INC. | $18.84 | 2020 | |
| Heron Therapeutics, INC. | $18.07 | 2024 | Zynrelef |
| Bioventus LLC | $16.96 | 2019 | |
| Halozyme INC | $16.92 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $15.89 | 2024 | Prevena, V.A.C. Veraflo |
| Ferring Pharmaceuticals INC. | $13.64 | 2019 | |
| Pfizer INC. | $13.48 | 2019 | |
| My01 INC. | $12.73 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Sanofi-Aventis U.S. LLC | $12.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kirk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.